CHIR 99021 Trihydrochloride in Organoid Workflows
2026-09-27
Learn how to use CHIR 99021 trihydrochloride to test GSK-3 inhibition in organoid and metabolic research without confusing a pathway perturbation with a complete differentiation protocol. Practical dose-finding, controls, and troubleshooting guidance connect the compound to tunable stem-cell assays while keeping the limits of the evidence clear.
AM 281 and the CB1–CREB–GLT-1 Axis in Brain Injury
2026-09-26
New mouse TBI findings connect CB1 signaling in astrocytes to GLT-1 expression, glutamate handling, neuronal survival, and cognitive outcomes. This article examines how AM 281 can help researchers test that pathway—and how to interpret its promise without overextending preclinical evidence.
Safe DNA Gel Stain for Microbiome Workflows
2026-09-26
Safe DNA Gel Stain supports sensitive DNA and RNA checks while allowing blue-light imaging to reduce reliance on UV exposure. This practical guide connects gel-based quality control to microbiome and cloning workflows, with protocol starting points and troubleshooting guidance.
Balsalazide for Active Ulcerative Colitis: 2009 Review
2026-09-25
Wiggins and Rajapakse reviewed evidence for balsalazide, a prodrug that uses colonic bacterial azoreduction to release 5-aminosalicylic acid (5-ASA) in the large intestine. Their review found evidence supporting induction of remission in mild-to-moderate active ulcerative colitis, while noting that comparative efficacy and onset claims depend on the clinical studies available at the time.
Standardized Whole-Blood Stimulation for Immunometabolism
2026-09-25
Zhao and colleagues describe a standardized whole-blood stimulation protocol for testing how metabolic interventions alter human immune-cell cytokine responses. Its central contribution is a practical framework for combining immune challenges, metabolic modulation, and cytokine measurement in a physiologically complex sample, while highlighting the need to separate pathway-specific effects from donor and stimulus variability.
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) Guide
2026-09-24
DOPE is a helper phospholipid for researchers formulating cationic liposomes and other lipid systems for nucleic acid delivery; it is supplied as a water-insoluble solid that requires suitable organic-solvent handling. Use it as a formulation component to evaluate, not as a standalone aqueous reagent or a guaranteed transfection enhancer, and validate composition and performance in the intended assay.
DOTAP: From Transfection Reagent to Assay Design
2026-09-24
DOTAP is a versatile cationic lipid for nucleic acid delivery, but its performance depends on formulation and biological context. This guide connects its practical use in transfection workflows with lessons from self-amplifying RNA research—and clarifies what that cardiac study does and does not show about DOTAP.
BOP Reagent for Peptide and Prodrug Workflows
2026-09-23
BOP reagent enables controlled carboxyl group activation for amide bond formation, phenyl ester preparation, and linker synthesis. This workflow connects practical solution-phase chemistry with the carrier-free, ROS-responsive prodrug strategy reported for targeted oral squamous cell carcinoma research.
7-AAD Cell Viability Assay Kit for CAR-T Studies
2026-09-22
The 7-AAD Cell Viability Assay Kit provides a practical membrane-integrity endpoint for separating viable cells from necrotic and late-apoptotic populations in CAR-T experiments. Its red-shifted, relatively narrow emission profile supports multiplex panels with Annexin V, Calcein AM, FITC, PE, or APC while helping investigators track target-cell killing and effector-cell fratricide.
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-22
The reference study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown provides a mechanistic framework for testing how nuclear-receptor signaling controls inflammatory aging.
Plk1 Control of Mitotic Checkpoint Disassembly
2026-09-21
Kaisaria and colleagues identify Polo-like kinase 1 as a direct regulator of p31comet, linking mitotic kinase activity to the timing of mitotic checkpoint complex disassembly. Their biochemical and cell-extract experiments show that Plk1 phosphorylation of p31comet at S102 suppresses its TRIP13-dependent activity, helping prevent premature checkpoint inactivation.
Light-Inducible RNA Release for Regulated Gene Therapy
2026-09-21
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls mammalian gene expression at the level of translational initiation. By combining compact allosteric regulation with AAV and cell-based delivery strategies, the work demonstrates externally tunable therapeutic activity in metabolic and retinal disease models while highlighting the remaining barriers to clinical translation.
M344 Histone Deacetylase Inhibitor Workflows
2026-09-20
M344 is a cell-permeable histone deacetylase inhibitor for connecting chromatin remodeling with proliferation, differentiation, apoptosis, migration, and treatment-response assays. This workflow translates evidence from neuroblastoma models into practical dose selection, assay design, troubleshooting, and combination-study strategies.
Berberine, RXRα/PPARγ, and SASP Inflammation
2026-09-19
A 2025 study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse disease modeling, Smart-seq transcriptomics, protein-mechanism assays, and macrophage-targeted RXRα knockdown provides a useful framework for testing PPARγ-dependent regulation of vascular senescence.
Podophyllotoxin: Mechanism and Research Workflow
2026-09-19
Podophyllotoxin is a plant-derived microtubule inhibitor used to study mitotic disruption, cell cycle arrest, and apoptosis. This guide separates the N1790 parent compound from Condyline formulations and from mechanistically distinct podophyllotoxin derivative 5p.